Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-12-31
pubmed:abstractText
Sanguis Draconis (SD) is a kind of dragon's blood resin that is obtained from Daemomorops draco (Palmae). It is used in traditional medicine and has shown anti-inflammatory activity in some diseases. In this study, we examined the effects of Sanguis Dranonis ethanol extract (SDEE) on LPS-induced inflammation using RAW 264.7 cells. Our data indicated that SDEE inhibits LPS-stimulated NO, PGE2, IL-1 beta and TNF-alpha release, and iNOS and COX-2 expression. Furthermore, SDEE suppressed the LPS-induced p65 expression of NF-kappa B, which was associated with the inhibition of I kappa B-alpha degradation. We also found that the expression of HO-1 was significantly increased in RAW 264.7 cells by SDEE. These results suggest among possibilities of anti-inflammation that SDEE inhibits the production of NO and PGE2 by the down-regulation of iNOS and COX-2 gene expression via the suppression of NF-kappaB (p65) activation. SDEE can induce HO-1 over-expression in macrophage cells, which indicates that it may possess antioxidant properties. This result means that SEDD its anti-inflammatory effects in macrophages may be through a novel mechanism that involves the action of HO-1. Thus, SD could provide a potential therapeutic approach for inflammation-associated disorders.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0378-8741
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-62
pubmed:meshHeading
pubmed-meshheading:18060707-Animals, pubmed-meshheading:18060707-Anti-Inflammatory Agents, pubmed-meshheading:18060707-Antioxidants, pubmed-meshheading:18060707-Arecaceae, pubmed-meshheading:18060707-Cell Line, pubmed-meshheading:18060707-Cyclooxygenase 2, pubmed-meshheading:18060707-Dinoprostone, pubmed-meshheading:18060707-Gene Expression Regulation, pubmed-meshheading:18060707-Heme Oxygenase-1, pubmed-meshheading:18060707-Inflammation, pubmed-meshheading:18060707-Lipopolysaccharides, pubmed-meshheading:18060707-Macrophages, pubmed-meshheading:18060707-Medicine, Traditional, pubmed-meshheading:18060707-Mice, pubmed-meshheading:18060707-Nitric Oxide, pubmed-meshheading:18060707-Nitric Oxide Synthase Type II, pubmed-meshheading:18060707-Plant Extracts, pubmed-meshheading:18060707-Resins, Plant
pubmed:year
2008
pubmed:articleTitle
Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells.
pubmed:affiliation
Emergency Department of Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC.
pubmed:publicationType
Journal Article